The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Transcriptional Cross Talk between NF-κB and p53
Open accessAbstract
Many cellular stimuli result in the induction of both the tumor suppressor p53 and NF-kappaB. In contrast to activation of p53, which is associated with the induction of apoptosis, stimulation of NF-kappaB has been shown to promote resistance to programmed cell death. These observations suggest that a regulatory mechanism must exist to integrate these opposing outcomes and coordinate this critical cellular decision-making event. Here we show that both p53 and NF-kappaB inhibit each other's ability to stimulate gene expression and that this process is controlled by the relative levels of each transcription factor. Expression of either wild-type p53 or the RelA(p65) NF-kappaB subunit suppresses stimulation of transcription by the other factor from a reporter plasmid in vivo. Moreover, endogenous, tumor necrosis factor alpha-activated NF-kappaB will inhibit endogenous wild-type p53 transactivation. Following exposure to UV light, however, the converse is observed, with p53 downregulating NF-kappaB-mediated transcriptional activation. Both p53 and RelA(p65) interact with the transcriptional coactivator proteins p300 and CREB-binding protein (CBP), and we demonstrate that these results are consistent with competition for a limiting pool of p300/CBP complexes in vivo. These observations have many implications for regulation of the transcriptional decision-making mechanisms that govern cellular processes such as apoptosis. Furthermore, they suggest a previously unrealized mechanism through which dysregulated NF-kappaB can contribute to tumorigenesis and disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Since p53 inhibits RELA by competing for CBP binding (Webster and Perkins, 1999), p53 likely limits the IL1 arm of the SASP by reducing NF-κB activity.”
From Mitochondrial Dysfunction Induces Senescence with a Distinct Secretory Phenotype (2016) · cites this paper as Webster and Perkins, 1999
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dignam, J. D., Lebovitz, R. M., & Roeder, R. G. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.5.1475 · Cited by 11,262
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
Baldwin, A. S. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.649 · Cited by 5,882
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063
An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death
Beg, A. A., & Baltimore, D. (1996) · Science · doi:10.1126/science.274.5288.782 · Cited by 3,047
Wang, C.-Y., Mayo, M., Korneluk, R., Goeddel, D., & Baldwin, A. (1998) · Science · doi:10.1126/science.281.5383.1680 · Cited by 2,950
TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB
Wang, C.-Y., Mayo, M. W., & Baldwin, A. S. (1996) · Science · doi:10.1126/science.274.5288.784 · Cited by 2,586
Suppression of TNF-α-Induced Apoptosis by NF-κB
Antwerp, D. J. V., Martin, S. J., Kafri, T., Green, D. R., & Verma, I. M. (1996) · Science · doi:10.1126/science.274.5288.787 · Cited by 2,581
A model for p53-induced apoptosis
Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/38525 · Cited by 2,500
p53: puzzle and paradigm.Preprint
Ko, L. J., & Prives, C. L. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,346
Kamei, Y., Xu, L., Heinzel, T., Torchia, J., Kurokawa, R., Gloss, B., Lin, S.-C., Heyman, R. A., Rose, D. W., Glass, C. K., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81118-6 · Cited by 2,150
A signature motif in transcriptional co-activators mediates binding to nuclear receptors
Heery, D. M., Kalkhoven, E., Hoare, S., & Parker, M. G. (1997) · Nature · doi:10.1038/42750 · Cited by 2,128
Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
Deng, C., Zhang, P., Wade Harper, J., Elledge, S. J., & Leder, P. (1995) · Cell · doi:10.1016/0092-8674(95)90039-x · Cited by 2,113
Structure, Regulation and Function of NF-kappaB
Siebenlist, U. K., Franzoso, G., & Brown, K. D. (1994) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.10.110194.002201 · Cited by 2,086
WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.
El‐Deiry, W. S., Harper, J. W., O'Connor, P. M., Velculescu, V. E., Ce, C., Jackman, J., Pietenpol, J. A., Burrell, M., De, H., & Wang, Y. (1994) · PubMed · Cited by 2,021
Liu, Z.-G., Hsu, H., Goeddel, D. V., & Karin, M. (1996) · Cell · doi:10.1016/s0092-8674(00)81375-6 · Cited by 1,937
Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB
Beg, A. A., Sha, W. C., Bronson, R. T., Ghosh, S., & Baltimore, D. (1995) · Nature · doi:10.1038/376167a0 · Cited by 1,828
Osborn, L., Kunkel, S. L., & Nabel, G. J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.7.2336 · Cited by 1,583
A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A
Yang, X., Ogryzko, V. V., Nishikawa, J., Howard, B. H., & Nakatani, Y. (1996) · Nature · doi:10.1038/382319a0 · Cited by 1,497
Chen, H., Lin, R. J., Schiltz, R. L., Chakravarti, D., Nash, A., Nagy, L., Privalsky, M. L., Nakatani, Y., & Evans, R. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80516-4 · Cited by 1,480
The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function
Torchia, J., Rose, D. W., Inostroza, J. A., Kamei, Y., Westin, S. K., Glass, C. K., & Rosenfeld, M. G. (1997) · Nature · doi:10.1038/42652 · Cited by 1,283
Steroid receptor coactivator-1 is a histone acetyltransferase
Spencer, T. E., Jenster, G. W., Burcin, M. M., Allis, C. D., Zhou, J., Mizzen, C. A., McKenna, N. J., Oñate, S. A., Tsai, S. Y., Tsai, M., et al. (1997) · Nature · doi:10.1038/38304 · Cited by 1,242
Zhong, H., Voll, R. E., & Ghosh, S. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80066-0 · Cited by 1,210
Yao, T., Oh, S. P., Fuchs, M., Zhou, N.-D., Ch'ng, L.-E., Newsome, D., Bronson, R. T., Li, E., Livingston, D. M., & Eckner, R. (1998) · Cell · doi:10.1016/s0092-8674(00)81165-4 · Cited by 1,018
Role of CBP/P300 in nuclear receptor signalling
Chakravarti, D., LaMorte, V. J., Nelson, M. C., Nakajima, T., Schulman, I. G., Juguilon, H., Montminy, M., & Evans, R. M. (1996) · Nature · doi:10.1038/383099a0 · Cited by 932
p53-Dependent apoptosis in the absence of transcriptional activation of p53-target genes
Caelles, C., Helmberg, A., & Karin, M. (1994) · Nature · doi:10.1038/370220a0 · Cited by 843
CREB-binding protein/p300 are transcriptional coactivators of p65
Gerritsen, M. E., Williams, A. J., Neish, A. S., Moore, S., Shi, Y., & Collins, T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.2927 · Cited by 820
Constitutive Activation of NF-κB during Progression of Breast Cancer to Hormone-Independent Growth
Nakshatri, H., Bhat‐Nakshatri, P., Martin, D. A., Goulet, R. J., & Sledge, G. W. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.7.3629 · Cited by 818
Bargou, R. C., Emmerich, F., Krappmann, D., Bommert, K., Mapara, M. Y., Arnold, W., Royer, H., Grinstein, E., Greiner, A., Scheidereit, C., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119849 · Cited by 757
Wathelet, M. G., Lin, C. H., Parekh, B. S., Ronco, L. V., Howley, P. M., & Maniatis, T. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80051-9 · Cited by 730
Regulation of NF-κB by Cyclin-Dependent Kinases Associated with the p300 Coactivator
Perkins, N. D., Felzien, L. K., Betts, J. C., Leung, K., Beach, D., & Nabel, G. J. (1997) · Science · doi:10.1126/science.275.5299.523 · Cited by 720
Self-citationBinding and modulation of p53 by p300/CBP coactivators
Lill, N. L., Grossman, S. R., Ginsberg, D., DeCaprio, J. A., & Livingston, D. M. (1997) · Nature · doi:10.1038/42981 · Cited by 693
Glass, C. K., Rose, D. W., & Rosenfeld, M. G. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80066-x · Cited by 691
Recruitment of p300/CBP in p53-Dependent Signal Pathways
Avantaggiati, M. L., Ogryzko, V. V., Gardner, K., Giordano, A., Levine, A. S., & Kelly, K. (1997) · Cell · doi:10.1016/s0092-8674(00)80304-9 · Cited by 668
NF-kappa B activation by ultraviolet light not dependent on a nuclear signal
Devary, Y., Rosette, C., DiDonato, J. A., & Karin, M. (1993) · Science · doi:10.1126/science.8367725 · Cited by 637
Stein, B., Baldwin, A. S., Ballard, D. W., Greene, W. C., Angel, P. E., & Herrlich, P. A. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06066.x · Cited by 630
Synergistic activation of transcription by CBP and p53
Gu, W., Shi, X.-L., & Roeder, R. G. (1997) · Nature · doi:10.1038/42972 · Cited by 599
Inhibition of NF‐kappaB/Rel induces apoptosis of murine B cells.
Wu, M., Lee, H., Bellas, R. E., Schauer, S. L., Arsura, M., Katz, D., Fitzgerald, M. J., Rothstein, T. L., Sherr, D. H., & Sonenshein, G. E. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00845.x · Cited by 575
HTLV-1 transactivator induces interleukin-2 receptor expression through an NF-κB-like factor
Leung, K., & Nabel, G. J. (1988) · Nature · doi:10.1038/333776a0 · Cited by 558
Requirement of NF-κB Activation to Suppress p53-Independent Apoptosis Induced by Oncogenic Ras
Mayo, M. W., Wang, C.-Y., Cogswell, P. C., Rogers-Graham, K., Lowe, S. W., Der, C. J., & Baldwin, A. S. (1997) · Science · doi:10.1126/science.278.5344.1812 · Cited by 530
Stein, B., Cogswell, P. C., & Baldwin, A. S. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.7.3964 · Cited by 516
Jiang, H., Lin, J., Su, Z., Collart, F., Huberman, E., & Fisher, P. B. (1994) · PubMed · Cited by 495
The p300/CBP family: integrating signals with transcription factors and chromatin
Shiama, N. (1997) · Trends in Cell Biology · doi:10.1016/s0962-8924(97)01048-9 · Cited by 488
NF-κB Activation: The IκB Kinase Revealed?
Stancovski, I., & Baltimore, D. (1997) · Cell · doi:10.1016/s0092-8674(00)80413-4 · Cited by 477
The nuclear hormone receptor coactivator SRC-1 is a specific target of p300.
Yao, T., Ku, G., Zhou, N., Scully, R., & Livingston, D. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.10626 · Cited by 456
Krikos, A., Laherty, C. D., & Dixit, V. M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)37138-8 · Cited by 444
Merika, M., Williams, A. J., Chen, G., Collins, T., & Thanos, D. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80028-3 · Cited by 435
Berger, S. L., Piña, B., Silverman, N., Marcus, G. A., Agapite, J., Regier, J. L., Triezenberg, S. J., & Guarente, L. (1992) · Cell · doi:10.1016/0092-8674(92)90100-q · Cited by 435
Smith, C. L., Oñate, S. A., Tsai, M., & O’Malley, B. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.8884 · Cited by 415
Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300
Horvai, A., Xu, L., Korzus, E., Brard, G., Kalafus, D., Mullen, T.-M., Rose, D. W., Rosenfeld, M. G., & Glass, C. K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.4.1074 · Cited by 415
p300/MDM2 complexes participate in MDM2-mediated p53 degradation
Grossman, S. R., Perez, M., Kung, A. L., Joseph, M., Mansur, C., Xiao, Z.-X., Kumar, S., Howley, P. M., & Livingston, D. M. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80140-9 · Cited by 414
IEX -1L, an Apoptosis Inhibitor Involved in NF-κB-Mediated Cell Survival
Wu, M. X., Ao, Z., Prasad, K. V. S., Wu, R., & Schlossman, S. F. (1998) · Science · doi:10.1126/science.281.5379.998 · Cited by 414
A requirement for NF-kappa B activation in Bcr-Abl-mediated transformationPreprint
Reuther, J. Y., Reuther, G. W., Cortez, D., Pendergast, A. M., & Baldwin, A. S., Jr. (1998) · Genes & Development · doi:10.1101/gad.12.7.968 · Cited by 401
Interaction and functional collaboration of p300 and C/EBPβ
Mink, S., Haenig, B., & Klempnauer, K. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.11.6609 · Cited by 346
Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathwayPreprint
Caelles, C., González‐Sancho, J. M., & Múñoz, A. (1997) · Genes & Development · doi:10.1101/gad.11.24.3351 · Cited by 327
(1995) · PubMed · Cited by 312
Tanaka, Y., Naruse, I., Maekawa, T., Masuya, H., Shiroishi, T., & Ishii, S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10215 · Cited by 299
The Signal-Dependent Coactivator CBP Is a Nuclear Target for pp90RSK
Nakajima, T., Fukamizu, A., Takahashi, J. B., Gage, F. H., Fisher, T., Blenis, J., & Montminy, M. (1996) · Cell · doi:10.1016/s0092-8674(00)80119-1 · Cited by 254
Catalysis by a Multiprotein IκB Kinase Complex
Maniatis, T. (1997) · Science · doi:10.1126/science.278.5339.818 · Cited by 246
Na, S.-Y., Lee, S., Han, S., Choi, H., Im, S., & Lee, J. W. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.18.10831 · Cited by 235
Perkins, N. D., Agranoff, A. B., Pascal, E., & Nabel, G. J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.10.6570 · Cited by 229
Self-citationPerkins, N. D., Schmid, R. M., Duckett, C. S., Leung, K., Rice, N. R., & Nabel, G. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1529 · Cited by 228
Self-citationIκB kinase: Beginning, not the end
Verma, I. M., & Stevenson, J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.22.11758 · Cited by 199
Activation of the cryptic DNA binding function of mutant forms of p53
Hupp, T. R., Meek, D. W., Midgley, C., & Lane, D. P. (1993) · Nucleic Acids Research · doi:10.1093/nar/21.14.3167 · Cited by 190
Achieving transcriptional specificity with nf-κb
Perkins, N. D. (1997) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(97)00088-5 · Cited by 183
Self-citationCorrection of Radiation Sensitivity in Ataxia Telangiectasia Cells by a Truncated IκB-α
Jung, M., Zhang, Y., Lee, S., & Dritschilo, A. (1995) · Science · doi:10.1126/science.7777860 · Cited by 171
Somasundaram, K., & El‐Deiry, W. S. (1997) · Oncogene · doi:10.1038/sj.onc.1201002 · Cited by 169
p53-mediated repression of nuclear factor-kappaB RelA via the transcriptional integrator p300.
Ravi, R. K., Mookerjee, B., van Hensbergen, Y., Bedi, G. C., Giordano, A., El‐Deiry, W. S., Fuchs, E. J., & Bedi, A. (1998) · PubMed · Cited by 156
Hottiger, M. O., Felzien, L. K., & Nabel, G. J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3124 · Cited by 137
Defective IκBα in Hodgkin cell lines with constitutively active NF-κB
Wood, K. M., Roff, M. A., & Hay, R. T. (1998) · Oncogene · doi:10.1038/sj.onc.1201735 · Cited by 127
MDM2-arbiter of p53's destruction
Lane, D. P., & Hall, P. A. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01119-5 · Cited by 126
Stein, B., Cogswell, P. C., & Baldwin, A. S. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.7.3964-3974.1993 · Cited by 120
Yan, Y., Shay, J. W., Wright, W. E., & Mumby, M. C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.24.15220 · Cited by 117
Induction of TNF‐sensitive cellular phenotype by c‐Myc involves p53 and impaired NF‐κB activation
Klefström, J. T., Arighi, E., Littlewood, T., Jäättelä, M., Saksela, E., Evan, G. I., & Alitalo, K. K. (1997) · The EMBO Journal · doi:10.1093/emboj/16.24.7382 · Cited by 117
Functional interplay between p53 and E2F through co-activator p300
Lee, C., Sørensen, T. S., Shikama, N., & Thangue, N. B. L. (1998) · Oncogene · doi:10.1038/sj.onc.1201818 · Cited by 115
EDITORIAL. p53—INTEGRATING THE COMPLEXITY
Hall, P. A., Meek, D. W., & Lane, D. P. (1996) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199609)180:1 · Cited by 112
Allday, M. J., Inman, G. J., Crawford, D., & Farrell, P. J. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00182.x · Cited by 109
A Role for Nuclear Factor κB in the Antiapoptotic Function of Insulin
Bertrand, F., Atfi, A., Cadoret, A., L’Allemain, G., Robin, H., Lascols, O., Capeau, J., & Cherqui, G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.5.2931 · Cited by 107
Donato, N. J., & Perez, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.9.5067 · Cited by 88
Vojtěšek, B., Dolezalova, H., Lauerová, L., Svitáková, M., Havlis, P., Kovařík, J., Midgley, C. A., & Lane, D. P. (1995) · PubMed · Cited by 72
Inhibition of Phorbol Ester-Induced Cellular Adhesion by Competitive Binding of NF-κB In Vivo
Eck, S. L., Perkins, N. D., Carr, D. P., & Nabel, G. J. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.10.6530-6536.1993 · Cited by 64
Self-citationTranscriptional squelching re-examined
Natesan, S., Rivera, V. M., Molinari, E., & Gilman, M. Z. (1997) · Nature · doi:10.1038/37019 · Cited by 56
Perkins, N. D., Agranoff, A. B., Pascal, E., et al. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.10.6570-6583.1994 · Cited by 55
Self-citationGualberto, A., Hixon, M. L., Finco, T. S., Perkins, N. D., Nabel, G. J., & Baldwin, A. S. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3450 · Cited by 37
Self-citationIsraë, A. (1997) · Nature · doi:10.1038/41433 · Cited by 35
Wu, B., Woffendin, C., MacLachlan, I., & Nabel, G. J. (1997) · Journal of Virology · doi:10.1128/jvi.71.4.3161-3167.1997 · Cited by 26
Induction of p53 DNA-binding activity by tumor necrosis factor-alpha
Mukhopadhyay, T., Roth, J. A., & Maxwell, S. A. (1996) · International Journal of Oncology · doi:10.3892/ijo.9.4.715 · Cited by 4
Flagged first, then by citations
Research works printed but not linked: 11
- Bannister A. J., 1995, Oncogene, 11, 2509
- Eck S. L., 1993, Mol. Cell. Biol., 13, 6530
- el-Deiry W. S., 1994, Cancer Res., 54, 1169
- 10.1073/pnas.94.4.1074 · DOI
- Israel A., 1997, Nature, 388, 519
- Jiang H., 1994, Oncogene, 9, 3397
- Mukhopadhyay T., 1996, Int. J. Oncol., 9, 715
- Perkins N. D., 1994, Mol. Cell. Biol., 14, 6570
- Ravi R., 1998, Cancer Res., 58, 4531
- Stein B., 1993, Mol. Cell. Biol., 13, 3964
- Vojtesek B., 1995, Oncogene, 10, 389
Cited by
Sorted by citations
Shared Principles in NF-κB Signaling
Hayden, M. S., & Ghosh, S. (2008) · Cell · doi:10.1016/j.cell.2008.01.020 · Cited by 4,954
The complexity of NF-κB signaling in inflammation and cancer
Hoesel, B., & Schmid, J. A. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-86 · Cited by 3,277
Live or let die: the cell's response to p53
Vousden, K. H., & Lü, X. (2002) · Nature reviews. Cancer · doi:10.1038/nrc864 · Cited by 3,231
NF-κB in cancer: from innocent bystander to major culprit
Karin, M., Cao, Y., Greten, F. R., & Li, Z. (2002) · Nature reviews. Cancer · doi:10.1038/nrc780 · Cited by 2,476
Integrating cell-signalling pathways with NF-κB and IKK function
Perkins, N. D. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2083 · Cited by 2,350
Self-citation
Metadata
- Authors
- Webster, G. A., & Perkins, N. D.
- Affiliations
- University of Dundee (GB)
- ORCID
- Perkins, Neil D.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 1999-05-01
- Volume
- 19
- Issue
- 5
- Pages
- 3485-3495
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC84141
- OpenAlex
- W2134542375
- Cited by
- 598
- References
- 87
- Citations by year
- 2026: 10 · 2025: 11 · 2024: 12 · 2023: 13 · 2022: 19 · 2021: 30 · 2020: 17 · 2019: 16 · 2018: 16 · 2017: 12 · 2016: 20 · 2015: 23 · 2014: 14 · 2013: 20 · 2012: 15
- FWCI
- 13.41
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Molecular and Cellular Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Royal Society
- Tenovus
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- NF-κB, p53, transcriptional crosstalk, RelA/p65, P300, CREB-binding protein, transcriptional coactivator, apoptosis, TNF-α, transcriptional repression, carcinogenesis
- MeSH terms
- Binding, Competitive, Cell Line, Gene Expression Regulation, Humans, Mutation, Repressor Proteins, Transcription, Genetic, Tumor Necrosis Factor-alpha, Ultraviolet Rays, Trans-Activators, Tumor Suppressor Protein p53, NF-kappa B, Apoptosis, Genes, Reporter, Transcription Factor RelA
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review